Betamethasone dipropionate and calcipotriol foam as an adjuvant therapy in patients with severe psoriasis treated with biologic drugs
Michał Adamczyk et al · Termedia Publishing House · 2024
Zugriff auf die Ressource
Öffnen Sie den Inhalt über die Hauptoption oder wählen Sie eine andere verfügbare Quelle.
Open Access verfügbar
Zitieren
Elegí el formato que necesitás y copiá la referencia al portapapeles.
APA 7
al, M. A. E. (2024). Betamethasone dipropionate and calcipotriol foam as an adjuvant therapy in patients with severe psoriasis treated with biologic drugs. https://doi.org/10.5114/dr.2023.136325
MLA
al, Michał Adamczyk et. "Betamethasone dipropionate and calcipotriol foam as an adjuvant therapy in patients with severe psoriasis treated with biologic drugs." 2024. https://doi.org/10.5114/dr.2023.136325.
Chicago
al, Michał Adamczyk et. 2024. "Betamethasone dipropionate and calcipotriol foam as an adjuvant therapy in patients with severe psoriasis treated with biologic drugs.". https://doi.org/10.5114/dr.2023.136325.
Harvard
al, M. A. E. 2024, Betamethasone dipropionate and calcipotriol foam as an adjuvant therapy in patients with severe psoriasis treated with biologic drugs, Termedia Publishing House, available at: https://doi.org/10.5114/dr.2023.136325 [Accessed 5 Aug. 2026].
Ressourcendetails
Bibliografische Angaben zur Prüfung, ob es sich um das richtige Material handelt.
- Titel
- Betamethasone dipropionate and calcipotriol foam as an adjuvant therapy in patients with severe psoriasis treated with biologic drugs
- Autor / Mitwirkende
- Michał Adamczyk et al
- Verlag
- Termedia Publishing House
- Erscheinungsjahr
- 2024
- ISSN
- 0033-2526
- ISSN
- 0033-2526
- Sprache
- Inglés
Schlagwörter
Entdecken Sie über diese Schlagwörter weitere verwandte Ressourcen.